APMD vs HELP: stock comparison and AI forecast
Apnimed, Inc. (APMD) and Helus Pharma Inc. (HELP) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
APMD Apnimed, Inc.
- Price
- $15.40 -46.5% · 6M
- Market Cap
- $627M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
HELP Helus Pharma Inc.
- Price
- $8.80 +66.4% · 6M
- Market Cap
- $660M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- APMD and HELP have similar market capitalizations ($627M and $660M).
- Over the last six months HELP returned +66.4% and APMD -46.5%.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | APMD | HELP |
|---|---|---|
| Market Cap | $627M | $660M |
Financial Health
| Metric | APMD | HELP |
|---|---|---|
| Current Ratio | 5.19x | – |
| Working Capital | $149M | – |
Dividend & Shareholder Information
| Metric | APMD | HELP |
|---|---|---|
| Shares Outstanding | 42M | 73M |
APMD vs HELP: stock comparison and AI forecast
Which is bigger, APMD or HELP?
APMD and HELP have similar market capitalizations ($627M and $660M).
Which stock performed better over the last six months, APMD or HELP?
Over the last six months HELP returned +66.4% and APMD -46.5%.
Which one does Intratio's AI model rank higher, APMD or HELP?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.